missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ LRRN2 Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA527923
This item is not returnable.
View return policy
Description
Recommended positive controls: U87-MG. Predicted reactivity: Mouse (93%), Rat (94%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
The protein encoded by this gene belongs to the leucine-rich repeat superfamily. This gene was found to be amplified and overexpressed in malignant gliomas. The encoded protein has homology with other proteins that function as cell-adhesion molecules or as signal transduction receptors and is a candidate for the target gene in the 1q32.1 amplicon in malignant gliomas. Two alternatively spliced transcript variants encoding the same protein have been described for this gene.
Specifications
| LRRN2 | |
| Polyclonal | |
| Unconjugated | |
| LRRN2 | |
| 5730406J09Rik; fibronectin type III, immunoglobulin and leucine rich repeat domain 7; FIGLER7; GAC1; Glioma amplified on chromosome 1 protein; leucine rich and ankyrin repeats 1; leucine rich repeat neuronal 2; leucine rich repeat neuronal 5; leucine rich repeat protein 2, neuronal; leucine-rich repeat neuronal protein 2; Leucine-rich repeat neuronal protein 5; LRANK1; LRRN2; LRRN5; NLRR-2; UNQ256/PRO293 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 10446 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot | |
| 1 mg/mL | |
| 0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7 | |
| O75325 | |
| LRRN2 | |
| Recombinant protein encompassing a sequence within the Extracellular domain of human LRRN2. The exact sequence is proprietary. | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction